Spots Global Cancer Trial Database for Immune Score Based Radiomics in Nasopharyngeal Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Immune Score Based Radiomics in Nasopharyngeal Carcinoma
Official Title: Immune Score Based Radiomics in Nasopharyngeal Carcinoma (IMRAN Study)
Study ID: NCT05126160
Conditions
Interventions
Study Description
Brief Summary: In nasopharyngeal carcinoma (NPC), tumor, node and metastasis (TNM) staging system is the main tool for determining treatment strategy and assessment of prognosis. However, the prognoses of patients with the same TNM stage after similar treatment vary widely. The aim of this study is to establish an immune score based radiomic staging system for NPC.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Renmin Hospital of Wuhan University, Wuhan, Hubei, China
Ningbo First Hospital, Ningbo, Ningbo, China
Ningbo Medical Center Lihuili Hospital, Ningbo, Ningbo, China
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Wenzhou, China
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Contact Details
Name: Xiaozhong Chen
Affiliation: Department of Radiation Oncology, Zhejiang Cancer Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
